K. K. Brown

发表

Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors.

A. Freemont, J. Woessner, J. Hoyland, 2001, Osteoarthritis and cartilage.

Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis

Bo Peng, T. Baker, M. Natchus, 2006, Inflammation Research.

Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.

A. Poole, C. Little, B. Caterson, 2004, Osteoarthritis and cartilage.

Development of N-4,6-pyrimidine-N-alkyl-N'-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase.

C. Hopkins, A. Gołębiowski, T. A. Brugel, 2006, Bioorganic & medicinal chemistry letters.

Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha production.

M. Natchus, R. Walter, R. Bookland, 2004, Journal of medicinal chemistry.

Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2.

Biswanath De, R. Walter, R. Bookland, 2006, Bioorganic & medicinal chemistry letters.

P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis

S. Heitmeyer, M. J. Janusz, L. Hsieh, 2008, Journal of Inflammation.

Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor.

A. Bendele, Y O Taiwo, M J Janusz, 2002, Osteoarthritis and cartilage.

P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis

M. J. Janusz, L. Hsieh, M. Buchalova, 2008, Journal of Inflammation.

The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones

R. Walter, A. Gołębiowski, M. J. Janusz, 2004 .